VALCYTE
CHEPLAPHARM ARZNEIMITTEL GMBH
Quick answers
Is there a shortage of VALCYTE in Canada?
No. There is no current shortage of VALCYTE 450MG reported to Health Canada. Stock can still vary from one pharmacy to another.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
MYLAN-VALGANCICLOVIR
MYLAN PHARMACEUTICALS ULC
TEVA-VALGANCICLOVIR
TEVA CANADA LIMITED
AURO-VALGANCICLOVIR
AURO PHARMA INC
NAT-VALGANCICLOVIR
NATCO PHARMA (CANADA) INC
MINT-VALGANCICLOVIR
MINT PHARMACEUTICALS INC
Other Products
VALCYTE
CHEPLAPHARM ARZNEIMITTEL GMBH
DIN
02245777
Strength
450MG
Dosage Form
Tablet
Route
Oral
Active Ingredient
VALGANCICLOVIR (VALGANCICLOVIR HYDROCHLORIDE)
See all VALGANCICLOVIR (VALGANCICLOVIR HYDROCHLORIDE) products →Compare with another product →
Shortage History
No shortage or discontinuation reports on file for this product.
Other Products from CHEPLAPHARM ARZNEIMITTEL GMBH
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
50MG · DIN 02221861
8MG · DIN 02239091
16MG · DIN 02239092
4MG · DIN 02239090
32MG · DIN 02311658
DIN 02332922
DIN 02244021
DIN 02332957
500MG · DIN 02162695
50MG · DIN 00029149
500MG · DIN 00465283
5MG · DIN 01911481